Measurement of aluminum in serum, blood, urine, and tissues of chronic hemodialyzed patients by use of electrothermal atomic absorption spectrometry.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  Clinical Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1093/CLINCHEM/31.1.24PMID 3965215
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Electrothermal atomic absorption determination of aluminum in tissues dissolved in tetramethyl ammonium hydroxide.

  1984cited by this paper
• Analytical problems related to Al-determination in body fluids, water and dialysate.

  1984cited by this paper
• Correlation of serum aluminum values with tissue aluminum concentration.

  1984cited by this paper
• Improved determination of aluminum in serum by electrothermal atomic absorption spectrophotometry.

  1983influential reference
• Effect of acute aluminium overload on calcium and parathyroid-hormone metabolism.

  1983cited by this paper
• An electrothermal atomic absorption method for aluminum analysis in plasma: identification of sources of contamination in blood sampling procedures.

  1983cited by this paper
• WATER TREATMENT AND DIALYSIS DEMENTIA

  1982cited by this paper
• Determination of aluminium in blood plasma or serum by electrothermal atomic absorption spectrometry

  1981cited by this paper
• Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

  1981cited by this paper
• Measuring aluminum levels.

  1980cited by this paper
• The determination of aluminum in biological fluids by means of graphite furnace atomic absorption spectrometry.

  1980cited by this paper
• Bone aluminium in haemodialysed patients and in rats injected with aluminium chloride: relationship to impaired bone mineralisation.

  1979cited by this paper
• Determination of aluminum in blood, urine, and water by inductively coupled plasma emission spectrometry.

  1979cited by this paper
• Aluminium toxicity syndrome.

  1978cited by this paper
• Determination of aluminum in biological samples by atomic absorption spectrophotometry with a graphite furnace.

  1978cited by this paper
• Gastrointestinal absorption of aluminum from aluminum-containing antacids.

  1977cited by this paper
• Measuring picogram amounts of aluminum in biological tissue by flameless atomic absorption analysis of a chelate.

  1976influential reference
• Determination of aluminium in biological tissue by flameless atomic absorption spectrometry.

  1976cited by this paper
• Studies on the mechanism of atom formation in graphite furnace atomic absorption spectrometry

  1976cited by this paper
• The dialysis encephalopathy syndrome. Possible aluminum intoxication.

  1976cited by this paper
• Aluminium in Bone from Patients with Renal Failure

  1971cited by this paper

• Aluminum toxicity to bone: A multisystem effect?

  2019cites this paper
• Urinary bromophenol glucuronide and sulfate conjugates: Potential human exposure molecular markers for polybrominated diphenyl ethers.

  2015cites this paper
• Excessive aluminum accumulation in the bones of patients on long-term parenteral nutrition: postmortem analysis by electrothermal atomic absorption spectrometry.

  2014cites this paper
• Al determination in whole blood samples as AlF via high-resolution continuum source graphite furnace molecular absorption spectrometry: potential application to forensic diagnosis of drowning

  2011cites this paper
• A study of the distribution of aluminium in human placental tissues based on alkaline solubilization with determination by electrothermal atomic absorption spectrometry.

  2010cites this paper
• Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.

  2007cites this paper
• Determination of serum aluminum by electrothermal atomic absorption spectrometry: A comparison between Zeeman and continuum background correction systems☆

  2007cites this paper
• Long-term changes in trace elements in patients undergoing chronic hemodialysis

  2006cites this paper
• Nephrology Dialysis Transplantation Diagnosis and treatment of aluminium bone disease

  2005cites this paper
• Adynamic Bone Disease - Clinical Outcome of the Treatment with Different Dialysate Calcium Concentration

  2005cites this paper
• Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy.

  2004cites this paper
• Clinical Chemistry through Clinical Chemistry: A Journal Timeline

  2004cites this paper
• Bone biopsy as a diagnostic tool in the assessment of renal osteodystrophy.

  2004cites this paper
• KineticFluorometricDeterminationof Aluminumin Serum

  2004cites this paper
• Bone biopsy in the diagnosis of renal osteodystrophy.

  2004cites this paper
• Useful biochemical markers for diagnosing renal osteodystrophy in predialysis end-stage renal failure patients.

  2003cites this paper
• Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis.

  2003cites this paper
• Inactivation of human glutamate dehydrogenase by aluminum

  2003cites this paper
• Randomized, crossover study of the effect of vitamin C on EPO response in hemodialysis patients.

  2003cites this paper
• Effects of Aluminum on Glutamate Metabolism

  2002cites this paper
• Direct and simultaneous determination of copper, chromium, aluminum, and manganese in urine with a multielement graphite furnace atomic absorption spectrometer.

  2001cites this paper
• Pamidronate therapy as prevention of bone loss following renal transplantation.

  2000cites this paper
• Transferrin-mediated uptake of aluminium by human parathyroid cells results in reduced parathyroid hormone secretion.

  2000cites this paper
• Effects of aluminum exposure on glutamate metabolism: a possible explanation for its toxicity.

  2000cites this paper
• Increased bone strontium levels in hemodialysis patients with osteomalacia.

  2000cites this paper
• Metal release and excretion from cementless titanium alloy total knee replacements.

  1999cites this paper
• Disturbance of cerebral function in people exposed to drinking water contaminated with aluminium sulphate: retrospective study of the Camelford water incident

  1999cites this paper
• Appraisal of different electrothermal atomic absorption spectrometric methods for the determination of strontium in biological samples

  1999cites this paper
• Aluminum, iron, lead, cadmium, copper, zinc, chromium, magnesium, strontium, and calcium content in bone of end-stage renal failure patients.

  1999cites this paper
• Increased serum strontium levels in dialysis patients: an epidemiological survey.

  1999cites this paper
• Low serum aluminum values in dialysis patients with increased bone aluminum levels.

  1998cites this paper
• Deproteinization of blood serum by acid treatment and microwave irradiation for the determinationof aluminium by electrothermal atomicabsorption spectrometry

  1998cites this paper
• Silicon and aluminium interactions in haemodialysis patients.

  1998cites this paper
• Al and Si: their speciation, distribution, and toxicity.

  1998cites this paper
• Strontium causes osteomalacia in chronic renal failure rats.

  1998cites this paper
• Aluminium speciation in cerebrospinal fluid of acutely aluminium-intoxicated dialysis patients before and after desferrioxamine treatment; a step in the understanding of the element's neurotoxicity.

  1997cites this paper
• Competition of iron and aluminum for transferrin: the molecular basis for aluminum deposition in iron-overloaded dialysis patients?

  1997cites this paper
• Measurement of strontium in serum, urine, bone, and soft tissues by Zeeman atomic absorption spectrometry.

  1997cites this paper
• Analysis of aluminium in serum and urine for the biomonitoring of occupational exposure.

  1997cites this paper
• High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population.

  1997cites this paper
• Is aluminum toxicity responsible for uremic pruritus in chronic hemodialysis patients?

  1997cites this paper
• Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients

  1996cites this paper
• The role of silicic acid in the renal excretion of aluminium.

  1996cites this paper
• Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients.

  1996cites this paper
• Low-dose (5 mg/kg) desferrioxamine treatment in acutely aluminium-intoxicated haemodialysis patients using two drug administration schedules.

  1996cites this paper
• Determination of serum and urinary aluminum by HPLC with fluorometric detection of Al-lumogallion complex.

  1996cites this paper
• Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients.

  1996cites this paper
• Diagnosis and treatment of aluminium bone disease.

  1996cites this paper
• Increased silicon levels in dialysis patients due to high silicon content in the drinking water, inadequate water treatment procedures, and concentrate contamination: a multicentre study.

  1995cites this paper
• Use of the low-dose desferrioxamine test to diagnose and differentiate between patients with aluminium-related bone disease, increased risk for aluminium toxicity, or aluminium overload.

  1995cites this paper
• Influence of hydroxypyridones and desferrioxamine on the mobilization of aluminium from tissues of aluminium-loaded rats.

  1995cites this paper
• HPLC-AAS hybrid technique for studying the speciation of trace metals (Al, Fe, Si, Hg) in biological fluids: A review of applications, recent experiences and perspectives

  1995cites this paper
• Loss of regional bone mineral density in the first 12 months following renal transplantation.

  1994cites this paper
• Silicon measurement in bone and other tissues by electrothermal atomic absorption spectrometry

  1994cites this paper
• Quantitative HPLC/ETAAS hybrid method with an on-line metal scavenger for studying the protein binding and speciation of aluminum and iron.

  1994cites this paper
• Chapter 1 Sampling and sample storage

  1994cites this paper
• Ultrastructural changes in brain parenchyma during normal aging and in animal models of aging.

  1994cites this paper
• Trace element reference values in tissues from inhabitants of the European Community. VII. Review of trace elements in blood, serum and urine of the Belgian population and critical evaluation of their possible use as reference values.

  1994cites this paper
• Silicon and aluminium and their inter‐relationship in serum and urine after renal transplantation

  1994cites this paper
• Chapter 13 Aluminium

  1994cites this paper
• Determination of aluminum levels in the kidney, liver, and brain of mice treated with aluminum hydroxide

  1994cites this paper
• An experimental animal model of aluminium overload.

  1994cites this paper
• Urinary and biliary excretion of aluminoxamine and ferrioxamine in dogs with various renal function.

  1994cites this paper
• Parathyroid sensing of the direction of change of calcium in uremia.

  1993cites this paper
• Determination of aluminium in different tissues of the rat by atomic absorption spectrometry with electrothermal atomization.

  1993cites this paper
• Aluminium toxicity in dialysis patients: no evidence for a threshold serum aluminium concentration.

  1993cites this paper
• Effect of citric acid and maltol on the accumulation of aluminum in rat brain and bone.

  1993cites this paper
• An evaluation of the biological significance of aluminium in plasma and hair of patients on long-term hemodialysis.

  1993cites this paper
• [Interlaboratory tests: completion of a method of aluminum assay in serum by electrothermal atomic absorption spectrometry].

  1992cites this paper
• Determination of lead and aluminium in port wine by electrothermal atomic absorption spectrometry

  1992cites this paper
• Measurement of Aluminium in Clinical Samples

  1992cites this paper
• Factors affecting plasma aluminum concentrations in nonexposed workers.

  1992cites this paper
• USE OF ZEEMAN GFAAS IN THE ANALYSIS OF TRACE ELEMENTS IN DIALYSIS FLUIDS

  1992cites this paper
• Dialysate calcium reduction in CAPD patients treated with calcium carbonate and alfacalcidol.

  1992cites this paper
• Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients.

  1992cites this paper
• Gastrointestinal absorption of aluminium in Alzheimer's disease: response to aluminium citrate.

  1992cites this paper
• Toxicity of aluminium: a historical review, Part 1.

  1992cites this paper
• A sequential and simple determination of zinc, copper and aluminium in blood samples by inductively coupled plasma atomic emission spectrometry.

  1992cites this paper
• DETERMINATION OF TRACE ELEMENTS IN BONE BY GFAAS WITH ZEEMAN CORRECTION

  1992cites this paper
• Blood aluminum levels as a function of aluminum intake from drinking water

  1991cites this paper
• The effect of tea on iron and aluminium metabolism in the rat

  1991cites this paper
• Direct calibration for determining aluminum in bone and soft tissues by graphite furnace atomic absorption spectrometry.

  1991cites this paper
• The biocompatibility of glass-poly(alkenoate) (Glass-Ionomer) cements: a review.

  1991cites this paper
• Aluminum speciation studies in biological fluids. Part 3. Quantitative investigation of aluminum-phosphate complexes and assessment of their potential significance in vivo.

  1990cites this paper
• Urinary Aluminium Excretion following Renal Transplantation and the Effect of Pulse Steroid Therapy

  1990cites this paper
• Iron overload and bone disease in chronic dialysis patients.

  1990cites this paper
• Determination of aluminum in bone in haemodialyzed patients, using inductively coupled argon plasma emission spectrometry.

  1990cites this paper
• Aluminium determination in biological samples

  1990cites this paper
• Quality control of aluminum measurements

  1990cites this paper
• Critical appraisal of two methods for determining aluminum in blood samples.

  1990cites this paper
• Erythropoietin, aluminium, and anaemia in patients on haemodialysis.

  1990cites this paper
• Aluminum encephalopathy: Experimental vs human

  1990cites this paper
• Aluminium release as a new factor in the estimation of alumina bioceramic implants.

  1990cites this paper
• Value of serum aluminium monitoring in dialysis patients: a multicentre study.

  1990cites this paper
• Intestinal Absorption of Aluminum

  1990cites this paper
• Aluminium accumulation/toxicity in dialysis patients: Monitoring, diagnosis and therapy∗

  1989cites this paper
• Aluminum speciation studies in biological fluids. Part 2. Quantitative investigation of aluminum-citrate complexes and appraisal of their potential significance in vivo.

  1989cites this paper
• Indirect measurement of desferrioxamine and its chelated compounds aluminoxamine and ferrioxamine by Zeeman atomic absorption spectrometry.

  1989cites this paper
• Recent developments in aluminum toxicology.

  1989cites this paper
• Direct determination of iron in urine and serum using graphite furnace atomic absorption spectrometry.

  1989cites this paper